Disease: Acute myelomonocytic leukemia
- <em>BRAF</em> mutation in myeloid neoplasm: incidences and clinical outcomes
- A bispecific T cell engager recruits both type 1 NKT and Vγ9Vδ2-T cells for the treatment of CD1d-expressing hematological malignancies
- A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia
- A case of acute myelomonocytic leukemia morphologically mimicking lymphoblastic leukemia
- A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
- A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML
- A new combination of monocytic scores to support diagnosis of chronic myelomonocytic leukemia according to novel classifications
- A novel 3q interstitial deletion including GATA2 and ZNF148: A case report
- A phase 1/2 study of azacitidine, venetoclax and pevonedistat in newly diagnosed secondary AML and in MDS or CMML after failure of hypomethylating agents
- A primary pediatric acute myelomonocytic leukemia with t(3;21)(q26;q22): A case report
- Acute myelomonocytic leukemia and T-lymphoblastic lymphoma as simultaneous bilineage hematologic malignancy treated with decitabine: A case report
- Acute onset of constrictive pericarditis due to acute myelomonocytic leukemia: A case and literature review
- AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR
- An unusual response to 5-azacitidine by a patient with chronic myelomonocytic leukemia
- Analysis of CSF3R mutations in atypical chronic myeloid leukemia and other myeloid malignancies
- Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms
- ATP1A1/BCL2L1 predicts the response of myelomonocytic and monocytic acute myeloid leukemia to cardiac glycosides
- Azacitidine (Vidaza<sup>®</sup>) in Pediatric Patients with Relapsed Advanced MDS and JMML: Results of a Phase I/II Study by the ITCC Consortium and the EWOG-MDS Group (Study ITCC-015)
- Azacitidine, lenalidomide and donor lymphocyte infusions for relapse of myelodysplastic syndrome, acute myeloid leukemia and chronic myelomonocytic leukemia after allogeneic transplant: the Azalena-Trial
- Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with <em>KMT2A</em> rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
- Case report: Genomic analysis of a therapy-related chronic myelomonocytic leukemia with KMT2A rearrangement that progressed to acute myeloid leukemia with acute promyelocytic leukemia-like features
- CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment
- CD371+ pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment
- Characteristics and clinical outcomes of patients with myeloid malignancies and DDX41 variants
- Chronic Myelomonocytic Leukemia Patients With Lysozyme Nephropathy and Renal Infiltration Display Markers of Severe Disease
- Chronic myeloproliferative neoplasm in adulthood in CBL syndrome harboring a splice-site <em>CBL</em> variant alongside a novel constitutional <em>CSF3R</em> variant
- Clinical Efficacy of Hypomethylating Agent Therapy in Patients with Chronic Myelomonocytic Leukemia
- Clinical Features and Prognosis of Multiple Myeloma Patients with Secondary Primary Malignancies
- Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review
- Clinicopathologic Spectrum of Lysozyme-Associated Nephropathy
- Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with <em>ASXL1</em> and <em>EZH2</em> gene mutations: A case report
- Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with ASXL1 and EZH2 gene mutations: A case report
- Comprehensive analysis of the HCK gene in myeloid neoplasms: Insights into biological functions, prognosis, and response to antineoplastic agents
- Concurrent Langerhans cell histiocytosis and acute myeloid leukemia: A rare presentation of a rare case
- Core-binding factor abnormalities involving chromosome 16 in acute myeloid leukaemia: prognostic and therapeutic implications
- Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT
- CPX-351 in higher risk myelodysplastic syndrome and chronic myelomonocytic leukaemia: a multicentre, single-arm, phase 2 study
- Cutaneous involvement in Ph-negative myeloproliferative neoplasms: from extramedullary hematopoiesis to myeloid metastasis with histiocytic differentiation. A systematic review of the literature
- Dual-receptor T cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML
- Dysimmune manifestations associated with myelodysplastic neoplasms and chronic myelomonocytic leukaemias
- Early occurrence of acute myelomonocytic leukemia (M4/M5) after liver transplantation: a case report
- Epigenetic regulation by ASXL1 in myeloid malignancies
- Estimating the prevalence of pediatric hematological malignancies in Al-Madinah Al-Munawwarah, Saudi Arabia
- Exploration of risk factors of platelet transfusion refractoriness and its impact on the prognosis of hematopoietic stem cell transplantation: a retrospective study of patients with hematological diseases
- FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse
- Gingival hyperplasia: An initial oral manifestation of acute myeloid leukemia
- Impact of <em>CSF3R</em> Mutation on Treatment Response and Survival of Patients with Acute Myeloid Leukemia
- Impact of CSF3R Mutation on Treatment Response and Survival of Patients with Acute Myeloid Leukemia
- Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation
- In vitro differentiation of myeloid suppressor cells (MDSC-like) from an immature myelomonocytic precursor THP-1
- Incidence and predisposing factors of infection in patients treated with hypomethylating agents
- Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation
- Infrequent Presentations of Chronic <em>NPM1</em>-Mutated Myeloid Neoplasms: Clinicopathological Features of Eight Cases from a Single Institution and Review of the Literature
- Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS
- Leukemia Cutis
- Leukemia Cutis-The Current View on Pathogenesis, Diagnosis, and Treatment
- Low Incidence of Relapse with a Moderate Conditioning Regimen of Fludarabine, Busulfan, and Melphalan for Patients with Myeloid Malignancies: A Single-Center Analysis of 100 Patients
- MDS/CMML from resource-limited region: Characteristics and comparison to tertiary reference European center
- Mesenchymal stromal cells in myeloid malignancies: Immunotherapeutic opportunities
- Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center
- Myeloid sarcoma incidentally found in lymph nodes dissected for advanced gastric cancer
- Myelomonocytic and monocytic acute myeloid leukemia demonstrate comparable poor outcomes with venetoclax-based treatment: a monocentric real-world study
- Natural history study of patients with familial platelet disorder with associated myeloid malignancy
- Natural History Study of Patients with Familial Platelet Disorder with Myeloid Malignancy
- Neurofibromatosis Symptom-Lacking B-Cell Lineage Acute Lymphoblastic Leukemia with Only an <em>NF1</em> Gene Pathogenic Variant
- Neurofibromatosis Symptom-Lacking B-Cell Lineage Acute Lymphoblastic Leukemia with Only an NF1 Gene Pathogenic Variant
- Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
- Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational, randomised, crossover, pharmacokinetics, phase 3 study
- PARP-1 improves leukemia outcomes by inducing parthanatos during chemotherapy
- Pediatric Hematopathology in the Era of Advanced Molecular Diagnostics: What We Know and How We Can Apply the Updated Classifications
- Phase 1/1b study of azacitidine and hedgehog pathway inhibitor sonidegib in patients with myeloid neoplasms
- Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes
- Phase to phase: Navigating drug combinations with hypomethylating agents in higher-risk MDS trials for optimal outcomes
- Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia
- PHF6 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia and acute myeloid leukemia
- Plasmacytoid dendritic cell neoplasms
- Population Pharmacokinetics of Oral Azacitidine, and Exposure-Response Analysis in Acute Myeloid Leukemia
- Potential value of high-throughput single-cell DNA sequencing of Juvenile myelomonocytic leukemia: report of two cases
- Preclinical characterization and clinical trial of CFI-400945, a polo-like kinase 4 inhibitor, in patients with relapsed/refractory acute myeloid leukemia and higher-risk myelodysplastic neoplasms
- Prognostic Value of Pretreatment Fetal Hemoglobin Levels in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukemia Treated with Azacitidine: A Single-center Retrospective Study
- Progression in Myeloid Neoplasms: Beyond the Myeloblast
- Proposals for Clinical Trials in Chronic Myelomonocytic Leukemia
- Pyoderma gangrenosum complicated with hematological malignancies: Two case reports
- RAB27B controls palmitoylation-dependent NRAS trafficking and signaling in myeloid leukemia
- Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
- Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11)
- Regulation of coagulation activation in newly diagnosed AML by the heme enzyme myeloperoxidase
- Results from phase 1 of the MANIFEST clinical trial to evaluate the safety and tolerability of pelabresib in patients with myeloid malignancies
- RNA splicing dysregulation in hematological malignancies
- Sabatolimab (MBG453) model-informed drug development for dose selection in patients with myelodysplastic syndrome/acute myeloid leukemia and solid tumors
- Severe Acute Kidney Injury Associated with Transformation of Chronic Myelomonocytic Leukemia into Acute Myeloid Leukemia: A Case Report
- Severe RAS-Associated Lymphoproliferative Disease Case with Increasing αβ Double-Negative T Cells with Atypical Features
- Spontaneous remission without treatment of acute myelomonocytic leukemia associated with COVID-19 infection
- STIMULUS-MDS2 design and rationale: a phase III trial with the anti-TIM-3 sabatolimab (MBG453) + azacitidine in higher risk MDS and CMML-2
- TFH lymphoma and associated clonal hematopoiesis
- The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China
- The immutable relevance of myeloid sarcomas: Clinicopathological study of fourteen cases
- Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking
- Two Cases of Juvenile Myelomonocytic Leukemia and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
- Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights